X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Realty & auto in limelight 
(Fri, 23 Jan 01:30 pm) 
 
Indian share markets continued to trade firm in the post-noon trading session. Barring consumer durable and IT, all the sectoral indices are trading in the green. Realty & auto are the biggest gainers today.

BSE-Sensex is up 246 points and NSE-Nifty is trading 64 points up. BSE Mid Cap is trading down marginally and BSE Small Cap index is trading down by 0.5%. The rupee is trading at 61.48 to the US dollar.

Majority of the FMCG stocks are trading weak led by Procter & Gamble Hygiene & Healthcare and Lakshmi Energy. Jyothy laboratories and Hindustan Unilever are among the few stocks trading in the red. As per a leading financial daily, the Income Tax Department has ordered several multinational companies mostly in the FMCG space to pay taxes on advertisement, marketing and sales promotional expenses (AMP) expenses incurred over and above the industry average. The tax department's argument in this case is that if an Indian subsidiary of a foreign multinational spends more than the average AMP expenses then the additional amount is going towards brand promotion and in turn creating marketing intangibles. Therefore the additional amount should be chargeable to tax under transfer pricing. Based on this additional ad-spend, companies like Hindustan Unilever, Procter & Gamble, L'Oreal, LG and Maruti Suzuki face tax demands. This move has been challenged in the Delhi High Court and the decision is expected in the next ten days. Apart from this multinational companies have also approached the Income Tax tribunal in this regard.

Domestic pharma stocks are trading mixed with Dishman Pharma and Wockhardt being the biggest gainers. However, Biocon and Glenmark Pharma are among the major losers. As per a leading financial daily, the US Food & Drug Administration (USFDA) has issued a ban on products from the manufacturing facilty of IPCA Laboratories in Ratlam, Madhya Pradesh. The company's facility received regulatory observations in July last year following inspection by USFDA. As a result the company had voluntarily suspended the shipments of the active pharmaceutical ingredient (API) from the facility to the US. With the situation remaining unresolved, the import alert has been issued by USFDA. IPCA has clarified that four API's namely Hydroxychloroquine Sulphate, Propanolol Hydrochloride, Trimethoprim and Ondansetron have been excluded from the import alert.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Realty & auto in limelight". Click here!

  
 

S&P BSE SENSEX


Apr 28, 2017 (Close)

MARKET STATS